Capstone Therapeutics Corp (CAPS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1275 WEST WASHINGTON STREET TEMPE, AZ 85281

Capstone Thera operates as a development stage company (Mar. 31, 2005) focused on healing of musculoskeletal, orthopedic, dermal and cardiovascular tissue through biopharmaceutical approaches. This drug development company's research highlights the potential commercialization of its Chrysalin Product Platform.

Data as of 2021-05-08 10:45:01 -0400
Market Cap2.855 Million Shares Outstanding79.277 Thousand Avg 30-day Volume608
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low36.01 / 15.0 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CAPS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CAPS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CAPS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALIMCO FINANCIAL CORP

  • SEE REMARKS
103,000 2019-01-24 0

SUBIN NEIL S

  • 10% Owner
7,554,422 2018-12-21 0

LIPMAN MATTHEW E.

BP PEPTIDES, LLC

  • Director
  • 10% Owner
18,541,197 2018-01-30 0

MILLER LLOYD I III

  • 10% Owner
4,742,938 2017-10-05 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2017-07-14 0

TOPOREK MICHAEL

  • Director
  • SEE EXPLANATION OF RESPONSES
0 2017-07-14 0

TAEGER LESLIE M SVP CHIEF FINANCIAL OFFICER

  • Officer
94,574 2017-01-04 0

HOWSE ELWOOD D

  • Director
0 2016-11-10 0

FELDMAN FREDRIC J

  • Director
0 2016-11-10 0

HOLLIMAN JOHN M III EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2016-01-22 0

FANGMANN ERIC W

  • Director
0 2016-01-22 0

STEER RANDOLPH C

  • CONSULTANT
0 2015-06-19 0

SPIEGEL ROBERT J.

  • Director
10,000 2012-01-01 0

WARDELL WILLIAM M

  • Director
145,702 2012-01-01 0

WHITE AUGUSTUS A

  • Director
197,877 2012-01-01 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
5,052,238 2011-07-26 0

BVF INVESTMENTS LLC

BVF PARTNERS L P/IL

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
3,192,600 2011-07-11 0

SHINBAUM DANA B VP BUSINESS DEVELOPMENT

  • Officer
0 2011-01-17 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
5,136,888 2008-10-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-13 15:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-13 14:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-13 14:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-13 13:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-13 13:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-13 12:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 22:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 21:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 21:15:02 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 20:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 20:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 19:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 19:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 18:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 18:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 17:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 17:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 16:45:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 16:15:03 UTC -0.9883 1.0483 500
CAPSTONE THERAPEUTICS CORP CAPS 2021-04-12 15:45:03 UTC -0.9883 1.0483 500

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments